Company: AZN
Filing Date: 2025-07-29
Form Type: 6-K
Source: 0001104659-25-071432
Chunk: 12

Company: ASTRAZENECA PLC
Filing Date: 2025-07-29
Form: 6-K
Chunk 12
---
 environmental impact of patient care, including its new Care pathways Environmental Sustainability Assessment tool (CARESA) |

| – | EVP International, Iskra Reic met with China’s Vice President Han Zheng to discuss the green transition as part of the Sustainable Markets Initiative (SMI) China Forum in Beijing. She underscored AstraZeneca’s commitment to Healthy China 2030 and Common Health, as well as the Company’s collaborative efforts to decarbonise the health sector in Chinese media interviews |

Health equity

| – | AstraZeneca’s Qure.ai partnership reached a significant milestone, achieving five million chest X-rays assessed by AI for lung cancer in more than 20 countries. This partnership has resulted in nearly 50,000 referrals for follow-up testing to date and demonstrates the transformative potential of technology and advanced data analytics for early lung cancer detection |

| – | At the World Health Assembly (WHA) in Geneva, Switzerland, AstraZeneca organised the first cancer planners’ summit with the Union for International Cancer Control, attended by more than 100 delegates from over 50 countries, |

20

and also hosted events on lung health, kidney disease and rare diseases. The Company engaged with leaders from countries including the US, Brazil, the UAE, Egypt, Malaysia and Spain as well as NGOs on topics spanning health equity, resilience and climate action

| – | Through the Company’s flagship health equity initiative, Healthy Heart Africa, the Company engaged at Africa Health ExCon 2025, where a national strategy for managing chronic kidney disease in Egypt was launched with government representatives |

Health systems resilience

| – | The Partnership for Health System Sustainability and Resilience (PHSSR) which the Company co-founded in 2020, added to its growing body of evidence, launching its EU Expert Advisory Group's report on sustainable healthcare financing in Europe |

| – | AstraZeneca convened the PHSSR Summit 2025 at EXPO in Osaka, Japan with AstraZeneca Chair Michel Demaré, Japanese government and health systems stakeholders. The Summit focused on action on non-communicable diseases (NCDs) and healthcare digitisation. Additional high-level engagements at EXPO 2025 this quarter included an event on transforming the delivery of healthcare with a focus on COPD, attended by EVP BioPharmaceuticals Business, Ruud Dobber, and engagements on rare disease led by Marc Dunoyer, CEO Alexion |

| – | At Abu Dhabi Global Health Week, a